Cipher Reports Strong Q3 2012 Financial Results

Cipher Reports Strong Q3 2012 Financial Results
CIP-TRAMADOL ER (ConZip®/Durela®) Cipher's extended-release tramadol for the treatment of moderate to moderately severe chronic pain, was launched in the U.S. by Vertical Pharmaceuticals in September 2011 under the trade name ConZip®. Vertical's …

Full News here – Read more on Equities.com

Leave a Reply